Addex Therapeutics Ltd. (ADXN) income statement
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.40+0.34 (+11.11%)
Close on Nov 19, 2026Market cap $69.81KP/E –Yield –
Addex Therapeutics Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -9390.8%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.76
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 56.2%
Valuation
- P/E ratio
- –
- Price to sales
- 1.95
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?